BioCentury | Apr 3, 2021
Management Tracks

Biotech CEOs in China: a broadening talent pool

...founded Anticancer Bioscience Ltd. to translate and commercialize research out of the J. Michael Bishop Institute of Cancer Research...
BioCentury | May 27, 2020
Emerging Company Profile

Versant’s Monte Rosa debuts with $32.5M, library of molecular glues for protein degradation

...of molecular glues and targets for targeted protein degradation Origin of technology: Versant Ventures’ Ridgeline, The Institute of Cancer Research...
...Cancer Clinical status: Preclinical Founded: 2018 by Versant, Raj Chopra and Ian Collins University collaborators: The Institute of Cancer Research...
BioCentury | Feb 29, 2020
Translation in Brief

Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation

...are Opher Gileadi at University of Oxford and Paul Workman, chief executive and president of The Institute of Cancer Research...
BioCentury | Oct 16, 2019
Company News

AI play Healx raises $56M to repurpose drugs for rare disease

...Partners include the FRAXA Research Foundation, which studies Fragile X, the Barth Syndrome Foundation and the Institute of Cancer Research...
BioCentury | Oct 11, 2019
Preclinical News

Oct. 10 Preclinical Quick Takes: Merck-Prokaryotics Inc.-Princeton ID new antibiotic class; plus NIH, Owkin, Genentech and ICR

...Phase II is planned. ICR announces preclinical data, trial launch for TTK inhibitor Scientists from the Institute of Cancer Research...
...to Foil Drug Resistance" ). BioCentury Staff National Institutes of Health Merck & Co. Inc. Prokaryotics Inc. Princeton University Owkin Inc. Genentech Inc. The Institute of Cancer Research Tryptase TTK...
BioCentury | Jun 3, 2019
Clinical News

June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more

...of MAPK1 and MAPK3. ICR study shows liquid biopsy predicts drug resistance A study from The Institute of Cancer Research...
...of Clinical Oncology Eli Lilly and Co. Five Prime Therapeutics Inc. Iovance Biotherapeutics Inc. Merck & Co. Inc. Moderna Inc. Celgene Corp. iberdomide LY3214996 The Institute of Cancer Research...
BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...Arch Venture Partners, Watson Fund and WRF Capital. The company’s program is in preclinical testing. The Institute of Cancer Research...
...Calif. Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Salk Institute for Biological Studies, La Jolla, Calif. The Institute of Cancer Research...
...demethylase 5B Karen Tkach Tuzman, Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer Research UK Dana-Farber Cancer Institute Francis Crick Institute The Institute of Cancer Research University...
BioCentury | Jan 16, 2019
Tools & Techniques

Researchers develop AI tool to improve screening for cervical cancer

...communities, including tools to diagnose malaria or cervical cancer and enhance farm productivity. Sandi Wong National Cancer Institute The Institute of Cancer Research National...
BioCentury | Jan 11, 2019
Emerging Company Profile

Artios: Probing DNA Damage

...status: Preclinical Founded: July 2016 by Cancer Research UK and SV Health Investors University collaborators: The Institute of Cancer Research...
BioCentury | Sep 26, 2018
Distillery Techniques

Assays and screens; other

...30, 2018 doi:10.1158/2159-8290.CD-17-0891 CONTACT: Nicola Valeri, The Institute of Cancer Research, Sutton, U.K. email: andrea.sottoriva@icr.ac.uk Claire Quang Erbitux, cetuximab (IMC-C225) Vectibix, panitumumab (ABX-EGF) The Institute of Cancer Research BRAF Epidermal...
Items per page:
1 - 10 of 163
BioCentury | Apr 3, 2021
Management Tracks

Biotech CEOs in China: a broadening talent pool

...founded Anticancer Bioscience Ltd. to translate and commercialize research out of the J. Michael Bishop Institute of Cancer Research...
BioCentury | May 27, 2020
Emerging Company Profile

Versant’s Monte Rosa debuts with $32.5M, library of molecular glues for protein degradation

...of molecular glues and targets for targeted protein degradation Origin of technology: Versant Ventures’ Ridgeline, The Institute of Cancer Research...
...Cancer Clinical status: Preclinical Founded: 2018 by Versant, Raj Chopra and Ian Collins University collaborators: The Institute of Cancer Research...
BioCentury | Feb 29, 2020
Translation in Brief

Genentech finds non-exhausted antitumor T cell source in blood, plus updates on Penn and Chordoma Foundation-Mark Foundation

...are Opher Gileadi at University of Oxford and Paul Workman, chief executive and president of The Institute of Cancer Research...
BioCentury | Oct 16, 2019
Company News

AI play Healx raises $56M to repurpose drugs for rare disease

...Partners include the FRAXA Research Foundation, which studies Fragile X, the Barth Syndrome Foundation and the Institute of Cancer Research...
BioCentury | Oct 11, 2019
Preclinical News

Oct. 10 Preclinical Quick Takes: Merck-Prokaryotics Inc.-Princeton ID new antibiotic class; plus NIH, Owkin, Genentech and ICR

...Phase II is planned. ICR announces preclinical data, trial launch for TTK inhibitor Scientists from the Institute of Cancer Research...
...to Foil Drug Resistance" ). BioCentury Staff National Institutes of Health Merck & Co. Inc. Prokaryotics Inc. Princeton University Owkin Inc. Genentech Inc. The Institute of Cancer Research Tryptase TTK...
BioCentury | Jun 3, 2019
Clinical News

June 3 ASCO Quick Takes: ORR of 32% for Celgene's iberdomide in MM; plus Five Prime, Iovance and more

...of MAPK1 and MAPK3. ICR study shows liquid biopsy predicts drug resistance A study from The Institute of Cancer Research...
...of Clinical Oncology Eli Lilly and Co. Five Prime Therapeutics Inc. Iovance Biotherapeutics Inc. Merck & Co. Inc. Moderna Inc. Celgene Corp. iberdomide LY3214996 The Institute of Cancer Research...
BioCentury | May 31, 2019
Targets & Mechanisms

Targeting cancer evolution offers a way to foil drug resistance

...Arch Venture Partners, Watson Fund and WRF Capital. The company’s program is in preclinical testing. The Institute of Cancer Research...
...Calif. Neon Therapeutics Inc. (NASDAQ:NTGN), Cambridge, Mass. Salk Institute for Biological Studies, La Jolla, Calif. The Institute of Cancer Research...
...demethylase 5B Karen Tkach Tuzman, Associate Editor Achilles Therapeutics Ltd. ApoGen Biotechnologies Inc. Cancer Research UK Dana-Farber Cancer Institute Francis Crick Institute The Institute of Cancer Research University...
BioCentury | Jan 16, 2019
Tools & Techniques

Researchers develop AI tool to improve screening for cervical cancer

...communities, including tools to diagnose malaria or cervical cancer and enhance farm productivity. Sandi Wong National Cancer Institute The Institute of Cancer Research National...
BioCentury | Jan 11, 2019
Emerging Company Profile

Artios: Probing DNA Damage

...status: Preclinical Founded: July 2016 by Cancer Research UK and SV Health Investors University collaborators: The Institute of Cancer Research...
BioCentury | Sep 26, 2018
Distillery Techniques

Assays and screens; other

...30, 2018 doi:10.1158/2159-8290.CD-17-0891 CONTACT: Nicola Valeri, The Institute of Cancer Research, Sutton, U.K. email: andrea.sottoriva@icr.ac.uk Claire Quang Erbitux, cetuximab (IMC-C225) Vectibix, panitumumab (ABX-EGF) The Institute of Cancer Research BRAF Epidermal...
Items per page:
1 - 10 of 163